<DOC>
	<DOCNO>NCT01912937</DOCNO>
	<brief_summary>To describe pharmacokinetics paclitaxel blood deliver paclitaxel coat percutaneous angioplasty balloon catheter result treatment de novo restenotic lesion ( ) , occluded/stenotic re-occluded/restenotic lesion ( ) .</brief_summary>
	<brief_title>Pharmacokinetic Study Drug-coated Angioplasty Balloons Superficial Femoral Popliteal Arteries :</brief_title>
	<detailed_description>This study investigate inhibition restenosis use CVI Paclitaxel-coated PTA Catheter treatment de-novo occluded/stenotic re-occluded/ restenotic superficial femoral popliteal artery . The propose clinical study prospective , non-randomized , single arm , multi-center , pharmacokinetic study . The objective study describe pharmacokinetics paclitaxel blood deliver CVI Paclitaxel-coated PTA Catheter result de novo occluded/restenotic re-occluded/restenotic lesion ( ) .</detailed_description>
	<mesh_term>Peripheral Arterial Disease</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<criteria>Male nonpregnant female great equal 18 year age . Subjects symptomatic leg ischemia , require treatment Superficial Femoral Artery ( SFA ) popliteal artery . Pregnant lactating female . Known intolerance study medication , paclitaxel contrast agent opinion investigator adequately pretreated .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Paclitaxel</keyword>
	<keyword>Percutaneous Transluminal Angioplasty</keyword>
	<keyword>Balloon Catheter</keyword>
	<keyword>Pharmacokinetic</keyword>
	<keyword>Peripheral Artery Disease</keyword>
	<keyword>PAD</keyword>
</DOC>